Serotonin modulator
A serotonin modulator is an antidepressant that works on serotonin in more than one way. It slows reuptake, the return of serotonin into the cell that released it, so more stays between cells, and it also acts directly on serotonin receptors, although the balance differs between the medicines. MedlinePlus puts vortioxetine (Trintellix in the US, Brintellix in the UK), vilazodone (Viibryd, not available in the UK) and trazodone in this class.
Also called: Serotonin modulators.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What is a serotonin modulator?
The name is a class label you will see on the page for your own medication rather than something you take by itself. It covers three medications in common use in the US, and the two actions are what they have in common: each one slows the reuptake of serotonin, and each one also acts on serotonin receptors.
The receptor part is what the name points at, and it is also the part the labels are careful about. The vilazodone label calls the drug a 5-HT1A receptor partial agonist, then says the net result of this action on serotonergic transmission and its role in the antidepressant effect of vilazodone are unknown.
What drugs are serotonin modulators?
Vortioxetine (Trintellix), vilazodone (Viibryd) and trazodone. MedlinePlus names each one a serotonin modulator, and all three are used for depression. They are not interchangeable: the receptors each one acts on differ, and so do the side effects people notice first.
- Vortioxetine (Trintellix): Approved in the US for major depressive disorder in adults. Its label says the antidepressant effect is not fully understood, but is thought to be related to enhancement of serotonergic activity in the central nervous system through inhibition of the reuptake of serotonin. The same label lists several other activities, among them 5-HT3 receptor antagonism and 5-HT1A receptor agonism, and says what those add to the antidepressant effect is not established. Nausea, constipation and vomiting are the most common reactions, with nausea in 21% to 32% of people depending on the dose, against 9% on placebo. Its mean terminal half-life is about 66 hours, the longest of the three.
- Vilazodone (Viibryd): Also approved for major depressive disorder in adults, and a 5-HT1A receptor partial agonist on top of blocking serotonin reuptake. Its label reports diarrhea in 26% to 29% of people, nausea in 22% to 24%, insomnia in 6% to 7% and vomiting in 4% to 5%, depending on the dose. Terminal half-life is about 25 hours.
- Trazodone: Used for depression, and known to many people for sedation. Its label describes it as both a selective serotonin reuptake inhibitor and a 5-HT2 receptor antagonist. Among reactions reported in 5% or more of people and at least twice as often as on placebo, the label lists drowsiness, fatigue, blurred vision, edema, syncope, diarrhea, nasal congestion and weight loss.
How is a serotonin modulator different than an SSRI?
An SSRI works on reuptake alone. The Lexapro label says the mechanism of antidepressant action of escitalopram is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from its inhibition of neuronal reuptake of serotonin.
The difference is not in the name. The trazodone label calls trazodone both a selective serotonin reuptake inhibitor and a 5-HT2 receptor antagonist, so one of the three carries the SSRI name itself. What these three add to blocking reuptake is an action on receptors, and the labels call the contribution of that action unknown. All three are approved for depression, and none of their labels claims a better result than an SSRI. What usually decides the choice with your prescriber is the side effect you want to avoid and what you have already tried.
Why does serotonin syndrome come up with this class?
Because all three raise serotonergic activity, so all three labels carry the warning. The Trintellix label says the risk goes up when the medication is taken with other serotonergic agents, among them triptans, tricyclic antidepressants, fentanyl, tramadol, lithium, buspirone, amphetamines and St John’s wort, and higher again with a drug that slows serotonin metabolism such as an MAOI, and that it can also happen on the one medication alone. A 2023 review in Basic and Clinical Pharmacology and Toxicology describes the core the same way, neuromuscular excitation with autonomic dysfunction and altered mental status, in someone whose serotonergic treatment is new or has just been changed, and says it can come from therapeutic use or overdose of one serotonergic drug or from two of them interacting.
The Trintellix label sorts the signs into mental status changes, autonomic instability, neuromuscular symptoms, stomach symptoms and seizures, and the serotonin syndrome page in this glossary goes through each group. What the label asks for is to discontinue treatment and any other serotonergic agents immediately if these symptoms appear, and to start supportive treatment. The 2023 review puts it the same way, that early recognition and treatment are crucial to prevent significant morbidity, so this is a same-day call to your prescriber even for mild symptoms. For a high temperature, stiff muscles, a racing heart, confusion or a seizure, call 911, or ask someone with you to call.
What to do
Ask your prescriber why this class rather than an SSRI, and which side effect they expect you to notice in the first two weeks. Bring one list of everything you take, prescription, over the counter and supplements, so it can be checked for serotonin interactions. Ask what to do if signs of serotonin syndrome appear, and write that answer down. Stopping is a conversation too: MedlinePlus says not to stop vortioxetine without talking to your doctor, who will probably lower the dose gradually, and the trazodone label asks for the dosage to be reduced gradually rather than stopped abruptly whenever possible. Ask for that plan before you need it.
See trazodone side effects in detail
How withClaro helps
- Log how you feel each day, next to the dose you took
- See which week a side effect started
- Share a PDF report with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- U.S. National Library of Medicine. Vortioxetine. MedlinePlus, 2025.
- U.S. National Library of Medicine. Vilazodone. MedlinePlus, 2025.
- U.S. National Library of Medicine. Trazodone. MedlinePlus, 2025.
- U.S. Food and Drug Administration. Trintellix (vortioxetine) tablets: prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Vilazodone hydrochloride tablets: prescribing information. FDA / DailyMed, 2024.
- U.S. Food and Drug Administration. Trazodone hydrochloride tablets: prescribing information. FDA / DailyMed, 2025.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- Mikkelsen N, Damkier P, Pedersen SA. Serotonin syndrome: a focused review. Basic & Clinical Pharmacology & Toxicology, 2023.
All glossary terms